July 11, 2019

The database, called Biobank, is now one of the largest genetic databases in the country, in today's bite-sized hospital and health industry news from California, Massachusetts, Michigan, and Ohio.

  • California: A University of California, Los Angeles (UCLA) employee may have exposed students to measles when he ate lunch at the Court of Sciences Student Center food court last week, the university announced. The employee was diagnosed with measles on Monday. UCLA officials notified employees who may have been exposed to the disease, and said that employees who do not have proof of immunity will not be able to come to work until it is proven that they do not have measles, according to Administrative Vice Chancellor Michael Beck (Karlamangla, Los Angeles Times, 7/9).

  • Massachusetts: Partners Healthcare on Monday announced that its genetic database, Biobank, has more than 100,000 participants, making it one of the largest genetic databases in the country. The genetic information in the database has been used in more than 200 studies that examine genetics' role in cancer, cerebral aneurysms, rheumatoid arthritis, and other conditions. Scott Weiss, principal investigator for Biobank, said, "Greater participation in the Biobank enables us to increase the scale and scope of our research and provides our researchers with access to data and information that would otherwise take them years to source" (Park, Becker's Hospital Review, 7/8).

  • Michigan/Ohio: Michigan-based Beaumont Health has signed a letter of intent to acquire Ohio-based Summa Health. Through the deal, Beaumont would acquire one health insurance operation and four hospitals. The deal would also mark the health system's first purchase of a company that is outside of Michigan. Beaumont CEO John Fox said he hopes the merger will close before the end of this year and that he does not expect the deal to present state or federal antitrust concerns (Greene, Modern Healthcare, 7/9).

Genetic testing—and 7 other technologies that could transform health care

Our new report explores the clinical technology pipeline to help health care leaders become more conversant in the major vectors of innovation, leading applications of new technologies, and the business implications for established providers. Read on to unpack the new innovation agenda.

Download Now
Download Now

Topics